definiens: shall mean ESTRASORB ™, ANDROSORB ™ and, subject to Section 8.6 hereof, any hormone replacement therapy pharmaceuti cal product marketed in the field of women ’s health, including, but not limited to, those products that ( 1 ) include or use technology or Know How derived f rom ESTRASORB ™ or from ANDROSORB ™, ( 2 ) include or use t estosterone or any other anabolic or androgenic substance, or ( 3 ) contain a combination of a NOVAVAX Product and another pharmaceutical product . NOVAVAX Product shall specifically exclude any pharmaceutical or related products owned by NOVAVAX as a direct result of the c onsummation of the Fielding Acquisition Agreement ( as defined in the Note Purchase Agreement ) so long as any such pharma ceutical product or related product does not includ e or use ESTRASORB ™ or ANDROSORB ™ technology or Know How